New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial

INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis with an overall 5-year survival of approximately 8%. The success in reducing the mortality rate of PDAC is related to the discovery of new therapeutic agents, and to a significant extent to the development of early detectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Illés, Dóra, Ivány, Emese, Holzinger, Gábor, Kosár, Klára, Adam, M Gordian, Kamlage, Beate, Zsóri, Gábor, Tajti, Máté, Svébis, Márk M, Horváth, Viktor, Oláh, Ilona, Márta, Katalin, Váncsa, Szilárd, Zádori, Noémi, Szentesi, Andrea, Czakó, Bálint, Hegyi, Péter, Czakó, László
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678370/
https://www.ncbi.nlm.nih.gov/pubmed/33444177
http://dx.doi.org/10.1136/bmjopen-2020-037267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678370/
https://www.ncbi.nlm.nih.gov/pubmed/33444177
http://dx.doi.org/10.1136/bmjopen-2020-037267

Ejemplares similares